Lipid accumulation product and 25-OH-vitamin D deficiency in type 2 diabetes [0.03%]
2型糖尿病患者脂质积聚和25-羟基维生素D缺乏的相关性研究
Gianluca Bardini,Stefano Giannini,Desiderio Romano et al.
Gianluca Bardini et al.
Background: Emerging data suggest a link between vitamin D (25(OH)D) deficiency, type 2 diabetes (T2D), and visceral adiposity. The lipid accumulation product (LAP), strictly correlated with abdominal fat depots, is propo...
Resveratrol and diabetes [0.03%]
白藜芦醇与糖尿病
Natalia G Vallianou,Angelos Evangelopoulos,Christos Kazazis
Natalia G Vallianou
Resveratrol is a stilbene compound, and a phytoalexin, synthesized by plants in response to stressful stimuli, usually caused by infection. It is abundantly present in red wine, ports and sherries, red grapes, blueberries, peanuts, itadori ...
Metformin and cancer [0.03%]
二甲双胍与癌症
Natalia G Vallianou,Angelos Evangelopoulos,Christos Kazazis
Natalia G Vallianou
Metformin is well-known as an anti-diabetic drug, but it seems to possess anti-cancerous properties as well. Adenosine monophosphate-activated protein kinase (AMPK) is a highly conserved regulator of the cellular response to the presence of...
Paradoxical negative HDL cholesterol response to atorvastatin and simvastatin treatment in Chinese type 2 diabetic patients [0.03%]
阿托伐他汀和辛伐他汀治疗中国2型糖尿病患者的胆固醇负反应悖论现象分析
Yu-Hung Chang,Kun-Cheng Lin,Dao-Ming Chang et al.
Yu-Hung Chang et al.
Objectives: There is extensive but controversial evidence on the diverse effects of statins on the level of high-density lipoprotein cholesterol (HDL-C). Some of these effects may limit the benefits of statins in terms of...
Shu-Yi Wang,Ming-Chia Hsieh,Shih-Te Tu et al.
Shu-Yi Wang et al.
Dyslipidemia is a major risk factor for cardiovascular complications in people with diabetes. Lowering low-density lipoprotein cholesterol (LDL-C) levels is effective in the primary and secondary prevention of diabetic vascular complication...
Atherogenic dyslipidemia and combination pharmacotherapy in diabetes: recent clinical trials [0.03%]
糖尿病患者血脂异常与联合用药：最近临床试验进展
Sandra J Hamilton,Gerald F Watts
Sandra J Hamilton
Patients with type 2 diabetes (T2D) are at a markedly increased risk of cardiovascular disease (CVD). Dyslipidemia is a common risk factor and a strong predictor of CVD in T2D patients. Although statins decrease the incidence of CVD in T2D,...
Does combination therapy with statins and fibrates prevent cardiovascular disease in diabetic patients with atherogenic mixed dyslipidemia? [0.03%]
他汀类和贝特类药物联合治疗能否预防糖尿病混合型血脂异常患者的动脉粥样硬化性心血管疾病？
Aris P Agouridis,Christos V Rizos,Moses S Elisaf et al.
Aris P Agouridis et al.
Type 2 diabetes mellitus (T2DM) is associated with the development and progression of cardiovascular disease (CVD). Statins have an established efficacy in the management of dyslipidemia primarily by decreasing the levels of low-density lip...
Reassessing the benefits of statins in the prevention of cardiovascular disease in diabetic patients--a systematic review and meta-analysis [0.03%]
他汀类药物在糖尿病患者心血管疾病预防中效益的系统评价和meta分析
Yu-Hung Chang,Ming-Chia Hsieh,Cheng-Yuan Wang et al.
Yu-Hung Chang et al.
Objectives: Despite the fact that statins have been prescribed widely, cardiovascular disease (CVD) remains the leading cause of death in diabetic patients. The aim of this study was to reassess the benefits of statins fo...
Endothelial dysfunction in diabetes: pathogenesis, significance, and treatment [0.03%]
糖尿病的血管内皮功能障碍：发病机制、意义及治疗措施
Sandra J Hamilton,Gerald F Watts
Sandra J Hamilton
Type 2 diabetes (T2D) markedly increases the risk of cardiovascular disease. Endothelial dysfunction (ED), an early indicator of diabetic vascular disease, is common in T2D and independently predicts cardiovascular risk. Although the precis...
Yo-Chen Chang,Wen-Chuan Wu
Yo-Chen Chang
Diabetic retinopathy (DR) is one of the major microvascular complications of diabetes. In developed countries, it is the most common cause of preventable blindness in diabetic adults. Dyslipidemia, a major systemic disorder, is one of the m...